PainReform Ltd. (NASDAQ:PRFX – Get Free Report)’s share price rose 3.6% on Thursday . The stock traded as high as $1.43 and last traded at $1.42. Approximately 126,927 shares traded hands during trading, a decline of 67% from the average daily volume of 379,820 shares. The stock had previously closed at $1.37.
PainReform Trading Up 3.6%
The company’s 50 day moving average price is $1.47 and its two-hundred day moving average price is $1.87. The firm has a market cap of $2.85 million, a PE ratio of -0.01 and a beta of 0.58.
About PainReform
PainReform Ltd., a clinical stage specialty pharmaceutical company, focuses on the reformulation of established therapeutics and provides an extended period of post-surgical pain relief in Israel. It develops PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia, as well as in Phase 3 clinical trial for pain treatment of patients undergoing bunionectomy and second trial for pain treatment of hernia repair operations.
Further Reading
- Five stocks we like better than PainReform
- Financial Services Stocks Investing
- Why Seagate Is Wall Street’s New Favorite AI Infrastructure Play
- Election Stocks: How Elections Affect the Stock Market
- 3 AI Infrastructure Stocks With Upside After the Summer Rally
- Earnings Per Share Calculator: How to Calculate EPS
- Can Advantage2 Help Overcome D-Wave’s Share Price Plateau?
Receive News & Ratings for PainReform Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PainReform and related companies with MarketBeat.com's FREE daily email newsletter.
